XML 42 R30.htm IDEA: XBRL DOCUMENT v3.5.0.2
Discontinued Operations - AbbVie Separation (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]        
Net sales       $ 256
Earnings (Loss) Before Tax $ (3) $ (5) $ (6) 20
Income Tax Expense (Benefit) (19) (4) (266) (5)
Net Earnings (Loss) 16 (1) 260 25
Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax [Abstract]        
Pretax Gain     25 2,820
Tax Expenses from discontinued operations       1,100
After Tax Gain   (1) 16 1,736
Developed Markets Generics Pharmaceuticals And Animal Health Business        
Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]        
Net sales       256
Earnings (Loss) Before Tax (3) (5) (6) 20
Income Tax Expense (Benefit)     (3) 12
Net Earnings (Loss) (3) (5) (3) 8
Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax [Abstract]        
Pretax Gain       2,820
Tax Expenses from discontinued operations       1,084
After Tax Gain       1,736
AbbVie        
Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]        
Income Tax Expense (Benefit) (19) (4) (263) (17)
Net Earnings (Loss) 19 $ 4 263 $ 17
AbbVie | Proprietary Pharmaceuticals Business Assets and Liabilities Held for Disposal        
Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]        
Prepaid asset $ 293   $ 293